Pricing & Access

In today’s healthcare environment, the ability to secure pricing and reimbursement is just as critical as the ability to demonstrate clinical efficacy. At Elm Innovation Advisors, we help early-stage and emerging companies in therapeutics, diagnostics, and medtech understand how payers think, and build the strategies required to secure access, support value, and sustain growth.

We operate at the intersection of science, economics, and policy. Our work translates complex clinical and technical innovations into pricing and access strategies that resonate with global payers. We help clients think through how to position their products, what evidence will be required, and how to anticipate country-by-country or segment-by-segment variation in coverage and willingness to pay.

We engage across the development lifecycle—from preclinical asset planning to pre-launch market access strategy—and collaborate with cross-functional teams including medical affairs, health economics, finance, and commercial leads.

Our pricing and reimbursement services include:

• Global Pricing Strategy – defining value propositions and pricing architecture across U.S., EU, and other key markets

• Reimbursement Landscape Analysis – identifying coding, coverage, and payment mechanisms relevant to the target product and geography

• Payer Research and Advisory Boards – conducting primary payer research and testing positioning, evidence plans, and access risks

• Evidence Generation Strategy – aligning clinical development with HTA and payer expectations

• Launch Sequencing and Access Planning – guiding market prioritization and timing based on pricing and reimbursement outlook

• Value Dossiers and Communication Tools – supporting the articulation of value to internal stakeholders and external payers

We help our clients make pricing and access a strategic advantage, not an afterthought.